Proposed Special Issue
Launch a focused collection on thyroid cancer priorities.
Journal at a Glance
ISSN: 2574-4496
DOI Prefix: 10.14302/issn.2574-4496
License: CC BY 4.0
Peer reviewed open access journal
Scope Alignment
Thyroid carcinoma, endocrine oncology, surgical and medical management, molecular diagnostics, and survivorship care. We prioritize evidence that improves diagnosis and outcomes.
Publishing Model
Open access, single blind peer review, and rapid publication after acceptance and production checks. Metadata validation and DOI registration are included.
JTC welcomes proposals for special issues that highlight emerging priorities in thyroid cancer research and care. Special issues bring focused attention to fast moving topics and support collaborative research communities.
- Working title and thematic focus
- Rationale and relevance to thyroid oncology
- Proposed guest editors and affiliations
- Target audience and expected contribution
- Preliminary list of potential contributors
- Timeline for submissions and reviews
Scientific Value
Clear contribution to thyroid cancer care.
Clinical Impact
Relevance to diagnosis, treatment, or survivorship.
Editorial Capacity
Qualified guest editors with relevant expertise.
Feasibility
Realistic timelines and review capacity.
- Define scope and thematic boundaries
- Recommend reviewers and manage peer review
- Ensure ethical compliance and reporting quality
- Provide an editorial summary upon completion
The JTC editorial office supports special issue planning, reviewer coordination, and production workflows. Send proposals or questions to [email protected].
- Targeted therapy and resistance mechanisms
- Radioactive iodine optimization and biomarkers
- Thyroid surgery outcomes and innovation
- Molecular diagnostics and risk stratification
- Survivorship and quality of life
- Pediatric and hereditary thyroid cancers
- Define the thyroid cancer research gap the special issue addresses.
- Provide a rationale for guest editor expertise and topic coverage.
- Specify anticipated article types and approximate submission volume.
- Outline peer review timelines and editorial decision workflows.
- Describe outreach plans to endocrine oncology and surgical societies.
- Identify data reporting standards required for submissions.
- Clarify whether cross disciplinary submissions are in scope.
- List any planned invited contributions or consortium partners.
- Provide proposed metrics for impact or clinical relevance.
- Describe data harmonization requirements for multicenter submissions.
- Specify expected submission window and targeted publication date.
- Note any regulatory or guideline considerations for topic areas.
- Specify how guest editors will manage conflicts of interest.
- Outline plans for an editorial introduction or synthesis article.
- Describe collaboration with registries or clinical networks.
- Provide criteria for invited versus open submissions.
- Include data reporting checklists for imaging or molecular studies.
- State plans for dissemination to clinical stakeholders.
- Describe plans for consensus statements or clinical guidelines.
- Include expectations for molecular data reporting consistency.
- Outline strategies to recruit multidisciplinary contributors.
- Provide plans for patient centered outcomes reporting.
- Specify whether imaging datasets will be shared.
- Describe integration with ongoing clinical trials or registries.
- Outline dissemination plans for clinical audiences.
- Describe expectations for systematic review contributions.
- Provide plans for imaging standardization across sites.
- Clarify expectations for genomic data deposition.
- Describe strategies for harmonizing staging criteria.
- Outline editorial plans for companion reviews or commentaries.
- Specify patient advocacy or survivorship perspectives if applicable.
- Describe expectations for reporting long term outcomes.
Can proposals be co led by multiple institutions?
Yes. Collaborative proposals are encouraged.
How long should a special issue run?
Most run 3 to 6 months depending on scope.
Are invited papers allowed?
Yes. Clearly label invited submissions in the proposal.
JTC is committed to rigorous, transparent publishing in thyroid cancer research and care. We emphasize reproducible clinical methods, clear reporting of diagnostic criteria, and ethical compliance across all article types.
The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].
We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in endocrine oncology, surgical outcomes, and translational thyroid research.
Ready to Propose a Special Issue?
Share your idea with the editorial office to launch a focused collection.